ETON
Eton Pharmaceuticals Inc
NASDAQ: ETON · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$24.12
+2.29% today
Updated 2026-04-30
Market cap
$628.09M
P/E ratio
—
P/S ratio
7.86x
EPS (TTM)
$-0.17
Dividend yield
—
52W range
$13 – $27
Volume
0.4M
Eton Pharmaceuticals Inc (ETON) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-4.72M | $-8.14M | $-18.03M | $-22.35M | $-4.72M | $4.82M | $6.82M | $969000.00 | $10.52M |
| Capital expenditures | $130000.00 | $236000.00 | $1.85M | $50000.00 | $3.26M | $2.79M | $775000.00 | $26000.00 | $333000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $2.64M | $1.85M | $1.89M | $2.58M | $3.38M | $4.22M | $3.14M | $3.17M | $5.51M |
| Free cash flow | $-4.85M | $-8.38M | $-19.87M | $-22.40M | $-7.98M | $2.03M | $6.04M | $943000.00 | $10.19M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | $0.00 | $1.05M | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | $13.58M | $-14.67M | $9.23M | — | $1.90M | — | — | — |